Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 8 to 12, 2021. This …
Estimated Coverage With Measles Vaccine Down in 2020
Annual number of estimated measles deaths decreased 94 percent during 2000 to 2020, representing 31.7 million deaths averted
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot
But some experts say that demand could begin to recede in only a matter of weeks
Pfizer Asks FDA to Approve Booster Shots for All U.S. Adults
With its application, the company included early results of a study that involved 10,000 people
Adults With IBD Show Antibody Response to mRNA COVID-19 Vaccine
After mRNA COVID-19 vaccination, 99 percent of patients with IBD had detectable antibodies regardless of immunocompromising therapies
Biden Administration Presses Schools to Provide COVID-19 Shots to Children
White House also teaming up with AAP to have local physicians provide schools with science-based info about the vaccines
Pfizer Set to Ask FDA to Approve Booster for Those 18 and Older
Approval would fulfill the Biden administration’s plan to provide boosters for all adults and could increase booster rates at a critical point in the pandemic
Court Temporarily Blocks Biden’s Vaccine Mandate for Big Businesses
Lawsuit questions whether the federal government exceeded its authority in issuing the rule
New U.S. COVID-19 Vaccinations Climb for the Longest Stretch in Months
However, at least some of the recent surge in first doses could also be from incorrectly reported booster shots